| PND | paroxysmal nocturnal dyspnea; partial neck dissection; postnasal drainage; postnasal drip; postnatal... |
|---|---|
| POD | peroxidase; place of death; podiatry; polycystic ovary disease; pool of doctors; postoperative day; ... |
| pSIDS | partially unexplained sudden infant death syndrome |
| SCD | scleroderma; service-connected disability; sickle-cell disease; spinocerebellar degeneration; subacu... |
| SD | Sandhoff disease; senile dementia; septal defect; serologically defined; serologically detectable; s... |
| PCR-SSO | Polymerase chain reaction sequence-specific oligonucleotide |
|---|---|
| PCR-SSP | Polymerase chain reaction with sequence specific primers |
| PCR-SSP | Polymerase chain reaction-sequence specific primers |
| PS | Position Specific |
| PSBG | Pregnancy specific beta-1-glycoprotein |
| foetal mortality rate | <epidemiology> The ratio of foetal deaths divided by the sum of the births (the live births + the foetal deaths) in that year. In the United States, the foetal mortality rate plummeted from 19.2 per 1,000 births in 1950 to 9.2 per 1,000 births in 1980. (12 Dec 1998) |
|---|---|
| 5-year relative survival rate | <statistics> The likelihood that a patient will not die from causes associated with his or her cancer for at least 5 years after diagnosis. This is the standard many professionals use when determining someone a survivor of cancer. (16 Dec 1997) |
| lethality rate | <statistics> The proportion of deaths in a population or to a specific number of the population. (18 Nov 1997) |
| lowest achievable emissions rate | (LAER) Used to describe air emissions control technology. A rate of emissions defined by the permitting agency. LEAR sets emission limits for non-attainment areas. (05 Dec 1998) |